Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Wenbo Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4380-2236; OpenAlex author ID A5102890341. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 4 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. RNF187 neddylation in pancreatic cancer activates malignancy via IQGAP1-dependent actin cytoskeleton rearrangement. Co-author DOI 10.1038/s41388-025-03639-y↗
  2. Tumor Cell Derived Lnc-FSD2-31:1 Contributes to Cancer-Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular … Co-author DOI 10.1002/advs.202203324↗
  3. DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216288↗
  4. circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer. First author DOI 10.1186/s12943-023-01847-2↗
  5. Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. Co-author DOI 10.1186/s12967-023-04693-4↗
  6. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.655152↗
  7. Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Co-author DOI 10.3389/fonc.2021.630972↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongze Chen · 6 shared papers, 2021–2026 · strength 0.97
  2. Xinglong Geng · 5 shared papers, 2021–2023 · strength 0.69
  3. Guanqun Li · 5 shared papers, 2021–2023 · strength 0.69
  4. Chundong Cheng · 4 shared papers, 2021–2026 · strength 0.69
  5. Yongwei Wang · 4 shared papers, 2021–2023 · strength 0.57
  6. Zhongjie Zhao · 4 shared papers, 2021–2023 · strength 0.56
  7. Jisheng Hu · 4 shared papers, 2021–2023 · strength 0.56
  8. Bei Sun · 4 shared papers, 2021–2023 · strength 0.54
  9. Rui Kong · 3 shared papers, 2023 · strength 0.45
  10. Yangyang Zhang · 3 shared papers, 2023 · strength 0.44
  11. Danxi Liu · 3 shared papers, 2023 · strength 0.44
  12. Le Li · 3 shared papers, 2021–2023 · strength 0.44
  13. Bei Sun · 2 shared papers, 2023–2026 · strength 0.43
  14. Xuewei Bai · 2 shared papers, 2023–2026 · strength 0.42
  15. Liwei Liu · 2 shared papers, 2023 · strength 0.31
  16. Yan Luo · 2 shared papers, 2023 · strength 0.30
  17. Gang Wang · 2 shared papers, 2023 · strength 0.29
  18. Le Li · 2 shared papers, 2023 · strength 0.28
  19. Chengxiao Yang · 1 shared paper, 2026 · strength 0.28
  20. Xinyuan Liu · 1 shared paper, 2026 · strength 0.28
  21. Tao Zhang · 2 shared papers, 2021–2023 · strength 0.27
  22. Hongze Chen · 1 shared paper, 2023 · strength 0.15
  23. Bei Sun · 1 shared paper, 2023 · strength 0.15
  24. Zengfu Song · 1 shared paper, 2023 · strength 0.14
  25. Shangha Pan · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.